The Metabolic Syndrome Its Prevalence and Association with Coronary Artery Disease in Type 2 Diabetes

Size: px
Start display at page:

Download "The Metabolic Syndrome Its Prevalence and Association with Coronary Artery Disease in Type 2 Diabetes"

Transcription

1 REVIEW ARTICLE JIACM 2006; 7(1): 32-8 Abstract The Metabolic Syndrome Its Prevalence and Association with Coronary Artery Disease in Type 2 Diabetes Vijay Achari*, AK Thakur**, Arun K Sinha*** Objective: While the metabolic syndrome is a well recognised entity in type 2 diabetes, only a few international studies exist on the prevalence of this syndrome and its association with CAD. We examined these factors as well as other risk factors in data from a cardiac centre in Patna, India. Research design and methods: 928 diabetics (602 males, 326 females) attending the diabetic clinic of Heart Hospital between were assessed for the presence of metabolic syndrome (insulin resistance syndrome) using the criteria of Alberti and Zimmet as well as for the presence of coronary artery disease (CAD) by appropriate invasive and non-invasive methods of testing. Other major risk factors like smoking, hypertension, and dyslipidaemia were also assessed in this study. All patients had either ischaemic heart disease on the basis of ECG changes indicating definite ischaemia/infarction, or a positive treadmill test or other stress test, or had CABG/PTCA/angiographically documented disease. Results: 596 (64.2%) were positive for the metabolic syndrome while 516 (55.6%) tested positive for coronary artery disease; there was a strong correlation between these entities (p = < 0.001). When the individual components of the metabolic syndrome were tested for their relationship with coronary artery disease, it was found that obesity and microalbuminuria had the strongest association with the presence of ischaemic heart disease. Obesity (either central/visceral or generalised) was found in 452 (48.7%) diabetics, of which 282 (62.4 %) had ischaemic heart disease as compared to only 234 (49.1%) of 476 non obese diabetics with coronary artery disease (p = < ). Microalbuminuria was also strongly associated with CAD of the 312 with this condition 180 had ischaemic heart disease (p = < 0.001). Hypertension showed a weaker correlation (p = 0.03) while elevated triglyceride levels showed no association. Elevated total cholesterol and LDL cholesterol levels initially showed a weak association with CAD (p = 0.042); however, this was eliminated on multivariate logistic regression analysis. Smoking was strongly associated with the presence of CAD (p < 0.001).On multivariate logistic regression analysis the only factors associated with CAD were metabolic syndrome (p = 0.002), obesity (p = 0.000), hypertension (p = 0.033), nephropathy (p = 0.008) age (p = 0.000) and smoking (p = 0.006). Conclusion: It is therefore concluded that the presence of the metabolic syndrome is a strong marker indicating the likelihood of CAD, while the strongest associations of CAD were found with obesity and microalbuminuria. This seems more strongly significant than traditional risk factors like elevated LDL cholesterol, hypertension, and triglycerides. Key words: Coronary artery disease, Diabetes, Metabolic syndrome, Risk factors. Introduction Coronary artery disease (CAD) is the major cause of mortality and morbidity worldwide in type 2 diabetes, 65-80% of the deaths from type 2 diabetes are due to cardiovascular or cerebrovascular complications 1-3. It is estimated that the presence of diabetes exaggerates the risk of CAD 2-4 fold. A recent Finnish population based study suggested that type 2 diabetes proven MI have the same risk of MI as in non diabetics with proven MI 4. There is a considerable body of evidence that the metabolic syndrome (syndrome X) originally described by Reaven 5 and subsequently modified, plays a pivotal role in the development of this condition by providing a multitude of risk factors which tend to multiply the effect of each other on the vascular system. This effect is particularly pronounced in persons of south Asian origin 6. The importance of the metabolic syndrome as a single major risk factor in its own right has been recognised by Deedwania et al 7 and ATP III of the National Cholesterol Education Program 8. While there have been several studies on the prevalence of CAD in diabetics particularly in south India 9 and others 10, the exact prevalence of the metabolic syndrome and the importance of its individual components in the development of CAD is less well investigated in India. A recent study on young north Indian patients with CAD confirmed the association with metabolic syndrome, but * Department of Medicine, Patna Medical College Hospital, and Consultant Endocrinologist, Heart Hospital, Patna ** Medical Director, Heart Hospital, Patna, *** Department of Statistics, Patna University, Bihar.

2 the sample size was small and all the subjects were non diabetics with normal or impaired glucose tolerance. This study is an attempt to enhance the available knowledge in this field, as well as compare its relative importance with known and established risk factors. Research design and methods 928 patients having type 2 diabetes (602 males, 326 females) attending the out-patient or diabetic clinics of Heart Hospital, Kankarbagh, between were selected for this cross-sectional study. All patients had complete data including detailed history and physical examination which included examination of the waist-hip ratio (WHR), full biochemical data including a lipid profile, renal, hepatic, and thyroid function tests. Lipid profiles were taken from fasting blood samples; patient on lipid lowering drugs or other conditions that might alter the lipid profile were excluded from the study. Traditional risk factors for CAD like hypertension, smoking (cigarettes or bidis) were also considered in our analysis. The quality of diabetic control was assessed from the mean glycosylated haemoglobin (HbA1c) levels for one year during or prior to the study. The diagnosis of the metabolic syndrome was based on the following criteria as recommended by WHO 12 : 1. Impaired glucose regulation or diabetes. 2. Insulin resistance. 3. Raised arterial pressure 160/ Raised plasma triglyceride 150 mg/dl and/or low HDL cholesterol < 35 mg/dl in men, or < 39 mg/dl in women. 5. Central obesity (males: waist hip ratio, 0.9; females: waist to hip ratio 0.85) and/or generalised obesity (BMI30 kg/m 2 ). 6. Microalbuminuria: (UAER 20 g/min or albumin creatinine ratio 20 mg/g). To satisfy the criterion of metabolic syndrome, a patient needed to have either criterion (1) or (2) positive along with at least 2 of the 4 remaining criteria 2-6. Since all patients in the study were diabetic, insulin estimation was not considered necessary and the presence of 2 of 4 indirect criteria (criteria 2-6) was regarded as sufficient for the diagnosis. The diagnosis of coronary artery disease was based on the following criteria: 1. History of angina/mi with previously documented disease. 2. ECG following Minnesota codes 1-1, 4-1, 5-9, 5-2, or History of PTCA/CABG or angiographically documented disease. 4. A treadmill or stress echocardiogram study suggesting myocardial ischaemia. All patients who did not fulfill any of the criteria 1-3 had a stress test done in order to detect silent ischaemia. Patients with new or recent diagnosis of CAD were included in the study. Statistical analysis The data were analysed by standard statistical techniques: Student s test for interval data and Chi square for nominal data. A p-value less than 0.05 was regarded as significant. Presence of CAD was regarded as the dependent variable while other known and putative risk factors for CAD were independent variables. All these were subjected to multivariate logistic regression analysis using Minitab Statistical Software. Results The basic physical and biochemical characteristics of the diabetics are summarised in Table I. Males were significantly older, heavier, and had a higher waist/hip ratio (WHR). 596 (64.2%) patients fulfilled the criteria of the metabolic syndrome. Among the various constituents hypertriglyceridaemia was the most common, followed by obesity (of which visceral and generalised forms were present in nearly equal proportions), hypertension and microalbuminuria; low HDL cholesterol was the least common finding (Table II). The most common pattern of CAD was a history of stable angina/previous MI (301 patients, 52.6%). A positive stress test in asymptomatic diabetics was also fairly common (158 patients,27.6%) (Table IV). Journal, Indian Academy of Clinical Medicine Vol. 7, No. 1 January-March,

3 Table I: Basic physical and biochemical parameters and presence of metabolic syndrome. Males (n = 602) Females (n = 326) Mean P Age (years) ± ± ± 17.2 < 0.01 Duration of diabetes (yrs.) 8.62 ± ± ± 6.01 NS Mean wt. (kg) 60.4 ± ± ± 11.2 < 0.05 Mean waist-hip ratio (WHR) 0.89 ± ± < 0.01 Mean B. P. Systolic ± ± ± 19.7 NS Diastolic 87.4 ± ± ± 11.2 NS HbA1c (mean) 8.01 ± ± ± 1.32 NS Serum creatinine (mean) (mg/dl) 1.22 ± ± ± 1.02 NS Table II: Metabolic syndrome and type 2 diabetes analysis of individual components. Diabetics with Metabolic Syndrome = 596 (64.2%) Hypertension = 360 (38.9%) Obesity = 452 (48.7%) Generalised (combined with visceral) = 224* Visceral = 228 Hypertriglyceridaemia (triglycerides 150 mg/dl) = 516 (55.4%) Low HDL Cholesterol = 250 (26.9%) Microalbumiuria = 312 (33.6%) *All patients with generalised obesity also had visceral obesity; the reverse was not true. Of the 928 patients, 516 (55.6%) fulfilled at least one criterion of coronary artery disease. Diabetic patients with IHD were more often males and had a longer duration of diabetes. They were also significantly older than diabeties without CAD. They also had higher waist-hip ratio and mean body weight, systolic and diastolic BP. The quality of glycaemic control as manifested by glycosylated haemoglobin levels and renal function (serum creatinine levels) did not show any difference. Among traditional risk factors only an older age and smoking seemed very significant (Table III). The strongest correlation was found with obesity (both generalised and abdominal) and microalbuminuria. Hypertension was also associated with CAD but was weaker in significance. The other components of the metabolic syndrome (low HDL, elevated triglyerides) did not have any relationship with IHD. While elevated triglycerides were very common, levels were equally distributed in both groups (Table V). Mean total cholesterol level, LDL, and TC/HDL ratio showed an association, although comparatively weaker, with the presence of CAD (Table VI). An analysis of these data by multivariate logistic regression analysis (Table VII) showed that obesity (either central or generalised), older age, smoking history, nephropathy (manifested in most cases by microalbuminuria) and hypertension, in that order were important associations of CAD. The Metabolic syndrome (as a whole) was strongly associated with presence of CAD. On the contrary, an elevated triglyceride level or reduced HDL cholesterol failed to achieve statistical significance. The association of total cholesterol, LDL cholesterol, or HDL cholesterol was not found significant on multivariate analysis although it seemed to be weakly significant on univariate analysis (Table VI and VII). 34 Journal, Indian Academy of Clinical Medicine Vol. 7, No. 1 January-March, 2006

4 Table III: Comparison of some physical and biochemical features of the 2 groups of diabetics. Diabetes with Diabetes without P CAD (n = 516) CAD (n = 412) Mean age 59.4 ± ± 19.2 < 0.01 Sex Male Female Duration of diabetes (in yrs.) ± ± Mean wt. (kg) 61.3 ± ± 11.7 < 0.05 WHR (mean) 0.93 ± ± 0.12 < B.P. Systolic ± ± 19.1 < Diastolic 88.7 ± ± 10.7 Mean HbA1c 8.01 ± ± 2.26 NS Serum creatinine mg/dl (mean) 1.21 ± ± 0.68 NS Metabolic syndrome present < Metabolic syndrome absent < Smokers (recent or past 1 yr) < Table IV: Patterns of CAD in diabetics. Angina/previous MI 301 Treadmill/stress echo positive 158 Coronary angiography +ve 43 History of PTCA/CABG 14 Total 516 Discussion Both insulin resistance syndrome and coronary artery disease are very common in Asian Indians and it has been postulated that insulin resistance could probably be a culprit in the high prevalence of coronary artery disease in Indians 13. Type 2 diabetes is a heterogenous group and may be characterised by disorders of insulin action or insulin secretion, either of which may be a predominant feature. Haffner and coworkers 14 reported that insulin resistance was present in more than 85% of individuals with diabetes. The present study revealed a slightly lower prevalence of 64.2% possibly because indirect evidence (surrogate markers) of insulin resistance were used which are less sensitive than insulin stimulated glucose uptake by euglycaemic clamp technique. The prevalence of coronary artery disease was very high; more than half the patients (55.6%) with diabetes had some evidence of CAD. This is much higher than the figures of 17.8%, 15.7% and 19% respectively as reported by Mohan et al 9, Walia 10 and WHO 15. It is likely that the high prevalence was due to either: a. Late diagnosis of diabetes due to low socio-economic condition and poor health awareness. b. Presentation to a cardiac referral centre and a medical college hospital because of advanced or uncontrolled disease. c. Use of stress testing in all asymptomatic patients (the earlier studies by Walia and Mohan used only clinical and ECG criteria). As expected, there was a strong correlation of the metabolic syndrome as a whole with the presence of coronary artery disease. In particular, obesity and microalbuminuria was found to be markers for the presence of CAD. Older age was also a strong marker for CAD. This was in agreement with the results of Walia et al 10. Several other studies indicate that microalbuminuria is an indicator of early mortality from cardiovascular disease and maybe more important than the conventional risk factors. Elevated total cholesterol and LDL cholesterol showed a weak association with CAD on univariate analysis; however, this was not significant after multivariate analysis. Triglyceride and HDL cholesterol levels did not show any association at all with CAD. Journal, Indian Academy of Clinical Medicine Vol. 7, No. 1 January-March,

5 Table V: Correlation of the metabolic syndrome constituents with coronary artery disease. CAD present CAD absent P Metabolic syndrome present (n = 596) < Metabolic syndrome absent (n = 332) < Hypertension < 0.01 Obesity Generalised < Visceral Triglyeride level NS HDL Cholesterol NS Microalbuminuria or proteinuria < Table VI: Mean lipid levels in diabetes. Diabetes with Diabetes without P CAD (n = 516) CAD (n = 412) Mean total cholesterol (mg/dl) ± ± 32.8 < 0.05 Mean LDL cholesterol (mg/dl) ± ± Mean HDL cholesterol (mg/dl) ± ± 9.01 NS Mean triglyceride (mg/dl) ± ± NS TC / HDL ratio ± ± 0.36 < 0.05 Table VII: Logistic regression table (for all risk factors). Predictor Coeff. S.D. P value Odds ratio 95% C.I. Constant * Lower Metabolic syndrome (any combination) ** Age * Sex (male) Duration HbA1c TC HDL LDL VLDL TG Retinopathy Nephropathy (microalbuminuria) * Neuropathy Obesity (Generalised / visceral) ** Upper Hypertension * Smoking ** * Significant, ** Strongly significant 36 Journal, Indian Academy of Clinical Medicine Vol. 7, No. 1 January-March, 2006

6 A study by Ramachandran et al 19 indicated that central obesity was the most important cardiovascular risk factor in urban south Indians. Our study revealed that central as well as generalised obesity were nearly equally prevalent. In contrast to the study of Walia et al 10 and Mohan 9, abnormalities in lipid profile (e.g., elevated total cholesterol, LDL cholesterol, low HDL, abnormal TC/HDL ratio or high triglycerides did not appear to be significant factors on multivariate logistic regression analysis. The United Kingdom Prospective Diabetes Study (UKPDS) also indicated that elevated LDL cholesterol, decreased HDL cholesterol are major risk factors for CAD in diabetic subjects 20. The WHO multinational study and Paris prospective study 21 indicated that only hypertriglyceridaemia was significantly associated with CAD in diabetic patients. This observation requires further confirmation from detailed multicentric prospective studies on Indian diabetics. Another study by Mohan and others 22 in south India on the prevalence of diabetes, IGT and CAD indicated that only age and higher LDL cholesterol were associated with CAD; other factors did not achieve statistical significance. A study by Thulaseedharan and Augusti 23 showed similar results. There has been controversy about the importance of hypertriglyceridaemia as a risk factor for CAD 24, 25. However, a recent study by Rajmohan et al 26 on diabetic individuals surviving an MI showed no evidence of an association of isolated hypertriglyeridaemia with coronary artery disease. Our study did not show any association of triglycerides with CAD on multivariate analysis, and hence it is in agreement with the studies of Mohan and Rajmohan. The only recent major studies on the metabolic syndrome include a recent population based study by Isomaa and coworkers 27 in Finland and Sweden which concluded that the metabolic syndrome was present in 10% of subjects with normal glucose tolerance 50% of subjects with impaired fasting glucose or impaired glucose tolerance, and 80% of subjects with type 2 diabetes. The risk of coronary artery disease and stroke was markedly increased (nearly three-fold) in those with the syndrome and of the individual components microalbuminuria seemed the strongest predictor. Our results are slightly different in that obesity was more strongly associated with CAD than microalbuminuria. A more recent study by Lakka and coworkers in Finnish males 28 indicated that the metabolic syndrome as per WHO criteria was associated with times increased CVD mortality and times all cause mortality. These were also the findings of the San Antonio Heart Study 29. A recent study in India by Jhamb and others 30 has shown the importance of insulin resistance as a risk factor for carotid artery intima-media thickness (CCA-IMT), an indirect marker for atherosclerosis. It may therefore be summarised that both the metabolic syndrome and coronary artery disease are very common in type 2 diabetes. Obesity, microalbuminuria, and to a lesser extent hypertension, are strong markers indicating the presence of the latter supplanting the importance of many traditional risk factors. Among the traditional risk factors, only age and smoking seemed to be strongly significant. In a diabetic, with any of the components of the metabolic syndrome, a careful search should be made for the presence of CAD and all the associated conditions should be treated aggressively so that some of the profound and life threatening consequences of the disease may be prevented or alleviated. References 1. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors and 12 years cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 1993; 16: Schwortz CJ, Valente AJ, Spraque EA et al. Pathogenesis of the atherosclerotic lesion: Implications for diabetes mellitus. Diabetes Care 1992; 15: Grundy SM, Benjamin IJ, Burke GL et al. Diabetes and Cardiovascular Disease a statement for health care professionals from the American Heart Association. Circulation 1999; 100: Haffner Steven M, Lehto Seppo, Ronnemaa T et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in non diabetic subjects with and without prior myocardial infarction. N Eng J Med 1998; 339: Reaven GM. Banting Lecture Role of insulin resistance in human disease. Diabetes 1988; 37: Mc Keigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991; 387: Fagan T, Deedwania PC. The cardiovascular dysmetabolic syndrome. Am J Med 1998; 105 (suppl 1A): Journal, Indian Academy of Clinical Medicine Vol. 7, No. 1 January-March,

7 8. Executive Summary of the Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: Mohan V, Premlatha G, Sastry NG. Ischaemic heart disease in South Indian NIDDM subjects. Int J Diabetes Dev Countries 1995; 15: Walia Meenu, Agrawal AK, Shah P et al. Prevalence of coronary risk factors in Non-insulin Dependent (Type 2) Diabetes. JAPI 1999; 47: Misra A, Reddy RB, Reddy KS et al. Clustering of impaired glucose tolerance, hyperinsulinaemia and dyslipidaemia in young north Indian patients with coronary heart disease a preliminary case control study. Indian Heart J 1999; 51 (3): Alberti KGMM, Zimmet PZ, for the WHO consultation: Definition and diagnosis of complications. Part I Diagnosis and Classification of diabetes mellitus provisional report of a WHO consultation. Diab Med 1998; 15: Mc Keigue PM, Muller GJ, Marmot MG. Coronary heart disease in south Asians overseas a review. J Clin Epidemiol 1989; 42: Haffner SM, Mietinin H. Insulin resistance implications for type 2 diabetes mellitus and coronary heart disease. Am J Med 1997; 103: Kelly MW, Ahuja MMS, Bennett PH et al. The role of circulating glucose and triglyceride concentrations and their interaction with other risk factors as determinant of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care 1983; 6 (4): Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S et al. Urinary albumin excretion: an independent predictor of ischaemic heart disease. Arteriosel Thromb Vasc Biol 1999; 19: Kuusisto J, Mykkanen L, Pyoralla K, Laakso M. Hyperinsulinaemic microalbuminuria: a new risk factor for coronary heart disease. Circulation 1995; 91: Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin dependent diabetes mellitus: a systemic overview of the literature. Arch Int Med 1997; 157: Ramachandran A, Snehalatha C, Latha E, Vijay V, Satyavani K. Culstering of Cardiovascular risk factors in urban Asian Indians. Diabetes Care 1998; 21: Turner RC, Millnus H, Neel HAW et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus. United Kingdom prospective Diabetes Study (UKPDS: 23). BMJ 1998; 316: Fontbonne A, Eschwege E, Cambrene F et al. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality its subjects with impaired glucose tolerance or Diabetes: Results from the year follow-up of the Paris prospective study. Diabetelogia 1989; 32: Mohan V, Deep R, Rani SS, Premlatha C. Prevalence of Coronary artery disease and its relationship to lipids in a selected population in South India: the Chennai Urban Population Study (CUPS No. 5). J Am Coll Cardiol 2001; 38: Thulaseedharan N, Augusti KT. Risk factors for coronary heart disease in Non-insulin Dependent. Diabetes Mellitus Indian Heart J 1995; 47: Hokauson JE, Austin MA. Plasma triglyceride level as a risk factor for cardiovascular disease independent of HDL cholesterol level: A meta-analysis of population based prospective studies. J Cardiovasc Risk 1996; 3: Grundy SM. Hypertriglyceridaemia, atherogenic dyslipidaemia and the metabolic syndrome. Am J Cardiol 1998; 81: 18B. 26. Rajmohan L, Deepa R, Mohan Anjana, Mohan V. Association between Isolated Hypercholesterolaemia, Isolated Hypertriglyceridaemia and Coronary Artery Disease in South Indian Type 2 Diabetic Patients. Indian Heart J 2000; 52: Isomaa B, Almgren P, Tuomi T et al. Cardiovascular mortality and morbidity associated with the metabolic syndrome. Diabetes Care 2001; 24: Lakka HM, Laaksonen DE, Lakka TA et al. The metabolic syndrome and total and cardiovascular mortality in middle-aged men. JAMA 2002; 288: Hanley AJ, Williams K, Stern MP, Haffner SM. Homoeostasis model of insulin resistance in relation to the incidence of cardiovascular disease: The San Antonio Study. Diabetes Care 2002; 25: Jhamb Rajat,Gaiha M,Chakravarti AL, Daga MK.Insulin resistance/hyperinsulinaemia as a risk factor for Common Carotid artery Intima/Media thickness in Essential Hypertension.Journal of Indian Academy of Clinical Medicine (JIACM) 2005; 6 (2): Journal, Indian Academy of Clinical Medicine Vol. 7, No. 1 January-March, 2006

Association of Major Modifiable Risk Factors Among Patients with Coronary Artery Disease - A Retrospective Analysis

Association of Major Modifiable Risk Factors Among Patients with Coronary Artery Disease - A Retrospective Analysis Original Article Association of Major Modifiable Risk Factors Among Patients with Coronary Artery Disease - A Retrospective Analysis V Achari, AK Thakur Abstract Background : The relative importance of

More information

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD

More information

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010

Ischemic Heart and Cerebrovascular Disease. Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Ischemic Heart and Cerebrovascular Disease Harold E. Lebovitz, MD, FACE Kathmandu November 2010 Relationships Between Diabetes and Ischemic Heart Disease Risk of Cardiovascular Disease in Different Categories

More information

How to Reduce CVD Complications in Diabetes?

How to Reduce CVD Complications in Diabetes? How to Reduce CVD Complications in Diabetes? Chaicharn Deerochanawong M.D. Diabetes and Endocrinology Unit Department of Medicine Rajavithi Hospital, Ministry of Public Health Framingham Heart Study 30-Year

More information

Guidelines on cardiovascular risk assessment and management

Guidelines on cardiovascular risk assessment and management European Heart Journal Supplements (2005) 7 (Supplement L), L5 L10 doi:10.1093/eurheartj/sui079 Guidelines on cardiovascular risk assessment and management David A. Wood 1,2 * 1 Cardiovascular Medicine

More information

Strategies for the prevention of type 2 diabetes and cardiovascular disease

Strategies for the prevention of type 2 diabetes and cardiovascular disease European Heart Journal Supplements (2005) 7 (Supplement D), D18 D22 doi:10.1093/eurheartj/sui025 Strategies for the prevention of type 2 diabetes and cardiovascular disease Jaakko Tuomilehto 1,2,3 *, Jaana

More information

Plasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension

Plasma fibrinogen level, BMI and lipid profile in type 2 diabetes mellitus with hypertension World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086 Published by Atom and Cell Publishers All Rights Reserved Available online at: http://www.wjpsonline.org/ Original

More information

Frequency of Dyslipidemia and IHD in IGT Patients

Frequency of Dyslipidemia and IHD in IGT Patients Frequency of Dyslipidemia and IHD in IGT Patients *Islam MS, 1 Hossain MZ, 2 Talukder SK, 3 Elahi MM, 4 Mondal RN 5 Impaired glucose tolerance (IGT) is often associated with macrovascular complications.

More information

Metabolic Syndrome among Type-2 Diabetic Patients in Benghazi- Libya: A pilot study. Arab Medical University. Benghazi, Libya

Metabolic Syndrome among Type-2 Diabetic Patients in Benghazi- Libya: A pilot study. Arab Medical University. Benghazi, Libya Original Article Metabolic Syndrome among Type-2 Diabetic Patients in Benghazi- Libya: A pilot study Alshkri MM 1, Elmehdawi RR 2 1 Benghazi Diabetes Center. 2 Medical Department, Faculty of Medicine,

More information

Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk

Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk Metabolic Syndrome Update 21 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes University of Colorado Denver Denver Health Medical Center The Metabolic

More information

Metabolic Syndrome: What s in a name?

Metabolic Syndrome: What s in a name? Commentary Metabolic Syndrome: What s in a name? Deborah P. Wubben, MD, MPH; Alexandra K. Adams, MD, PhD Abstract The term metabolic syndrome has recently become en vogue. But is the definition realistic,

More information

Metformin should be considered in all patients with type 2 diabetes unless contra-indicated

Metformin should be considered in all patients with type 2 diabetes unless contra-indicated November 2001 N P S National Prescribing Service Limited PPR fifteen Prescribing Practice Review PPR Managing type 2 diabetes For General Practice Key messages Metformin should be considered in all patients

More information

Total risk management of Cardiovascular diseases Nobuhiro Yamada

Total risk management of Cardiovascular diseases Nobuhiro Yamada Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible

More information

Cardiovascular Complications of Diabetes

Cardiovascular Complications of Diabetes VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary

More information

A study of brachial artery flow mediated dilatation and carotid intima media thickness in subjects having risk factors for coronary artery disease

A study of brachial artery flow mediated dilatation and carotid intima media thickness in subjects having risk factors for coronary artery disease International Journal of Advances in Medicine http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20171037 A study of brachial

More information

Establishment of Efficacy of Intervention in those with Metabolic Syndrome. Dr Wendy Russell - ILSI Europe Expert Group

Establishment of Efficacy of Intervention in those with Metabolic Syndrome. Dr Wendy Russell - ILSI Europe Expert Group Establishment of Efficacy of Intervention in those with Metabolic Syndrome Dr Wendy Russell - ILSI Europe Expert Group Conflict of interest regarding this presentation: I have no conflict of interest to

More information

ARIC Manuscript Proposal #1233. PC Reviewed: 4_/_10/07 Status: _A Priority: 2_ SC Reviewed: Status: Priority:

ARIC Manuscript Proposal #1233. PC Reviewed: 4_/_10/07 Status: _A Priority: 2_ SC Reviewed: Status: Priority: ARIC Manuscript Proposal #1233 PC Reviewed: 4_/_10/07 Status: _A Priority: 2_ SC Reviewed: Status: Priority: 1.a. Full Title: Subclinical atherosclerosis precedes type 2 diabetes in the ARIC study cohort

More information

Journal of the American College of Cardiology Vol. 48, No. 2, by the American College of Cardiology Foundation ISSN /06/$32.

Journal of the American College of Cardiology Vol. 48, No. 2, by the American College of Cardiology Foundation ISSN /06/$32. Journal of the American College of Cardiology Vol. 48, No. 2, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.03.043

More information

Prevalence of Cardiovascular Risk Factors in Indian Patients Undergoing Coronary Artery Bypass Surgery

Prevalence of Cardiovascular Risk Factors in Indian Patients Undergoing Coronary Artery Bypass Surgery Original Article Prevalence of Cardiovascular Risk Factors in Indian Patients Undergoing Coronary Artery Bypass Surgery RR Kasliwal*, A Kulshreshtha**, Sweta Agrawal**, M Bansal***, N Trehan+ Abstract

More information

year resident, Department of Medicine, B. J. Medical college, Ahmedabad.

year resident, Department of Medicine, B. J. Medical college, Ahmedabad. Clinical Study of Type 2 Diabetes Mellitus Patients with or without Cerebrovascular Feature and Its Correlation with Other Comorbidity / Diabetic Complication Vivek Sidhapura 1*, Bipin Amin 2, Amit Potulwar

More information

Correlation between triglyceride level and carotid intima media thickness in patients with type 2 diabetes mellitus

Correlation between triglyceride level and carotid intima media thickness in patients with type 2 diabetes mellitus International Journal of Clinical Trials Bendwal K et al. Int J Clin Trials. 2018 May;5(2):97-101 http://www.ijclinicaltrials.com pissn 2349-3240 eissn 2349-3259 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3259.ijct20181051

More information

The American Diabetes Association estimates

The American Diabetes Association estimates DYSLIPIDEMIA, PREDIABETES, AND TYPE 2 DIABETES: CLINICAL IMPLICATIONS OF THE VA-HIT SUBANALYSIS Frank M. Sacks, MD* ABSTRACT The most serious and common complication in adults with diabetes is cardiovascular

More information

Original Research Article

Original Research Article A STUDY TO ESTIMATE SUBCLINICAL ATHEROSCLEROSIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS BY MEASURING THE CAROTID INTIMAL MEDIAL THICKNESS Natarajan Kandasamy 1, Rajan Ganesan 2, Thilakavathi Rajendiran

More information

Epidemiology of Diabetes, Impaired Glucose Homeostasis and Cardiovascular Risk. Eberhard Standl

Epidemiology of Diabetes, Impaired Glucose Homeostasis and Cardiovascular Risk. Eberhard Standl Epidemiology of Diabetes, Impaired Glucose Homeostasis and Cardiovascular Risk Eberhard Standl European Heart House Sophia Antipolis Thursday, June 17, 2010 IDF Diabetes Atlas 2009: Global Numbers Still

More information

Mortality from coronary heart disease (CHD), cardiovascular

Mortality from coronary heart disease (CHD), cardiovascular Epidemiology Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults Shaista Malik, MD, MPH; Nathan D. Wong, PhD, MPH;

More information

Diabetes Mellitus: A Cardiovascular Disease

Diabetes Mellitus: A Cardiovascular Disease Diabetes Mellitus: A Cardiovascular Disease Nestoras Mathioudakis, M.D. Assistant Professor of Medicine Division of Endocrinology, Diabetes, & Metabolism September 30, 2013 1 The ABCs of cardiovascular

More information

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease

Disclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease Disclosures Diabetes and Cardiovascular Risk Management Tony Hampton, MD, MBA Medical Director Advocate Aurora Operating System Advocate Aurora Healthcare Downers Grove, IL No conflicts or disclosures

More information

Diabetes, Diet and SMI: How can we make a difference?

Diabetes, Diet and SMI: How can we make a difference? Diabetes, Diet and SMI: How can we make a difference? Dr. Adrian Heald Consultant in Endocrinology and Diabetes Leighton Hospital, Crewe and Macclesfield Research Fellow, Manchester University Relative

More information

Diabetes Day for Primary Care Clinicians Advances in Diabetes Care

Diabetes Day for Primary Care Clinicians Advances in Diabetes Care Diabetes Day for Primary Care Clinicians Advances in Diabetes Care Elliot Sternthal, MD, FACP, FACE Chair New England AACE Diabetes Day Planning Committee Welcome and Introduction This presentation will:

More information

Diabetologia 9 Springer-Verlag 1991

Diabetologia 9 Springer-Verlag 1991 Diabetologia (1991) 34:590-594 0012186X91001685 Diabetologia 9 Springer-Verlag 1991 Risk factors for macrovascular disease in mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease

More information

1. Which one of the following patients does not need to be screened for hyperlipidemia:

1. Which one of the following patients does not need to be screened for hyperlipidemia: Questions: 1. Which one of the following patients does not need to be screened for hyperlipidemia: a) Diabetes mellitus b) Hypertension c) Family history of premature coronary disease (first degree relatives:

More information

The study of correlation of silent myocardial ischemia with microalbuminuria in patients of type 2 diabetes mellitus

The study of correlation of silent myocardial ischemia with microalbuminuria in patients of type 2 diabetes mellitus International Journal of Advances in Medicine Dua HS et al. Int J Adv Med. 2017 Dec;4(6):1506-1512 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20175120

More information

DYSLIPIDAEMIC PATTERN OF PATIENTS WITH TYPE 2 DIABETES MELLITUS. Eid Mohamed, Mafauzy Mohamed*, Faridah Abdul Rashid

DYSLIPIDAEMIC PATTERN OF PATIENTS WITH TYPE 2 DIABETES MELLITUS. Eid Mohamed, Mafauzy Mohamed*, Faridah Abdul Rashid Malaysian Journal of Medical Sciences, Vol. 11, No. 1, January 2004 (44-51) ORIGINAL ARTICLE DYSLIPIDAEMIC PATTERN OF PATIENTS WITH TYPE 2 DIABETES MELLITUS Eid Mohamed, Mafauzy Mohamed*, Faridah Abdul

More information

It is currently estimated that diabetes prevalence by

It is currently estimated that diabetes prevalence by clinical Study The Prevalence and Pattern of Dyslipidemia among Type 2 Diabetic Patients at Rural Based Hospital in Gujarat, India Hetal Pandya*, JD Lakhani**, J Dadhania, A Trivedi Abstract Only proper

More information

Prediction of Cardiovascular Disease in suburban population of 3 municipalities in Nepal

Prediction of Cardiovascular Disease in suburban population of 3 municipalities in Nepal Prediction of Cardiovascular Disease in suburban population of 3 municipalities in Nepal Koju R, Gurung R, Pant P, Humagain S, Yogol CM, Koju A, Manandhar K, Karmacharya B, Bedi TRS Address for Correspondence:

More information

Macrovascular Residual Risk. What risk remains after LDL-C management and intensive therapy?

Macrovascular Residual Risk. What risk remains after LDL-C management and intensive therapy? Macrovascular Residual Risk What risk remains after LDL-C management and intensive therapy? Defining Residual Vascular Risk The risk of macrovascular events and microvascular complications which persists

More information

How would you manage Ms. Gold

How would you manage Ms. Gold How would you manage Ms. Gold 32 yo Asian woman with dyslipidemia Current medications: Simvastatin 20mg QD Most recent lipid profile: TC = 246, TG = 100, LDL = 176, HDL = 50 What about Mr. Williams? 56

More information

Asubstantial minority of adults and adolescents

Asubstantial minority of adults and adolescents THE METABOLIC SYNDROME AS A RISK FACTOR FOR TYPE 2 DIABETES AND CARDIOVASCULAR DISEASE Roger S. Blumenthal, MD* ABSTRACT This paper discusses the prevalence and clinical significance of the metabolic syndrome

More information

Case Study: Chris Arden. Peripheral Arterial Disease

Case Study: Chris Arden. Peripheral Arterial Disease Case Study: Chris Arden Peripheral Arterial Disease Patient Presentation Diane is a 65-year-old retired school teacher She complains of left calf pain when walking 50 metres; the pain goes away after she

More information

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic CVD Risk Assessment Michal Vrablík Charles University, Prague Czech Republic What is Risk? A cumulative probability of an event, usually expressed as percentage e.g.: 5 CV events in 00 pts = 5% risk This

More information

Echocardiography analysis in renal transplant recipients

Echocardiography analysis in renal transplant recipients Original Research Article Echocardiography analysis in renal transplant recipients S.A.K. Noor Mohamed 1*, Edwin Fernando 2, 1 Assistant Professor, 2 Professor Department of Nephrology, Govt. Stanley Medical

More information

Patient referral for elective coronary angiography: challenging the current strategy

Patient referral for elective coronary angiography: challenging the current strategy Patient referral for elective coronary angiography: challenging the current strategy M. Santos, A. Ferreira, A. P. Sousa, J. Brito, R. Calé, L. Raposo, P. Gonçalves, R. Teles, M. Almeida, M. Mendes Cardiology

More information

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk The Metabolic Syndrome Update 2018 Marc Cornier, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine

More information

Identification of subjects at high risk for cardiovascular disease

Identification of subjects at high risk for cardiovascular disease Master Class in Preventive Cardiology Focus on Diabetes and Cardiovascular Disease Geneva April 14 2011 Identification of subjects at high risk for cardiovascular disease Lars Rydén Karolinska Institutet

More information

THE EFFECT OF VITAMIN-C THERAPY ON HYPERGLYCEMIA, HYPERLIPIDEMIA AND NON HIGH DENSITY LIPOPROTEIN LEVEL IN TYPE 2 DIABETES

THE EFFECT OF VITAMIN-C THERAPY ON HYPERGLYCEMIA, HYPERLIPIDEMIA AND NON HIGH DENSITY LIPOPROTEIN LEVEL IN TYPE 2 DIABETES Int. J. LifeSc. Bt & Pharm. Res. 2013 Varikasuvu Seshadri Reddy et al., 2013 Review Article ISSN 2250-3137 www.ijlbpr.com Vol. 2, No. 1, January 2013 2013 IJLBPR. All Rights Reserved THE EFFECT OF VITAMIN-C

More information

Review of guidelines for management of dyslipidemia in diabetic patients

Review of guidelines for management of dyslipidemia in diabetic patients 2012 international Conference on Diabetes and metabolism (ICDM) Review of guidelines for management of dyslipidemia in diabetic patients Nan Hee Kim, MD, PhD Department of Internal Medicine, Korea University

More information

Rehabilitation and Research Training Center on Secondary Conditions in Individuals with SCI. James S. Krause, PhD

Rehabilitation and Research Training Center on Secondary Conditions in Individuals with SCI. James S. Krause, PhD Disclosure The contents of this presentation were developed with support from educational grants from the Department of Education, NIDRR grant numbers H133B090005, H133B970011 and H133G010160. However,

More information

Metabolic syndrome is a constellation of

Metabolic syndrome is a constellation of A Study of Metabolic Syndrome and its Components in Type 2 Diabetes Mellitus Subjects and their Asymptomatic First-degree Relatives JL Patel*, AM Suthar*, VB Dalsaniya*, AP Parikh**, NN Suthar, KL Patel

More information

Metabolic syndrome is a constellation of

Metabolic syndrome is a constellation of A Study of Metabolic Syndrome and its Components in Type 2 Diabetes Mellitus Subjects and their Asymptomatic First-degree Relatives JL Patel*, AM Suthar*, VB Dalsaniya*, AP Parikh**, NN Suthar, KL Patel

More information

CHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION

CHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION CHAPTER 3 DIABETES MELLITUS, OBESITY, HYPERTENSION AND DYSLIPIDEMIA IN ADULT CENTRAL KERALA POPULATION 3.1 BACKGROUND Diabetes mellitus (DM) and impaired glucose tolerance (IGT) have reached epidemic proportions

More information

Journal of the American College of Cardiology Vol. 38, No. 3, by the American College of Cardiology ISSN /01/$20.

Journal of the American College of Cardiology Vol. 38, No. 3, by the American College of Cardiology ISSN /01/$20. Journal of the American College of Cardiology Vol. 38, No. 3, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01415-2 Prevalence

More information

Hypertension and Associated Cardiovascular Risk Factors in Kelantan

Hypertension and Associated Cardiovascular Risk Factors in Kelantan , ORIGINAL ARTICLE 0 Hypertension and Associated Cardiovascular Risk Factors in Kelantan M Mafauzy, FRCP, N Mokhtar, MD, W B Wan Mohamad, FRCP Department of Medicine, School of Medical Sciences, Universiti

More information

A Study to Show Postprandial Hypertriglyceridemia as a Risk Factor for Macrovascular Complications in Type 2 Diabetis Mellitus

A Study to Show Postprandial Hypertriglyceridemia as a Risk Factor for Macrovascular Complications in Type 2 Diabetis Mellitus Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2018/21 A Study to Show Postprandial Hypertriglyceridemia as a Risk Factor for Macrovascular Complications in Bingi Srinivas

More information

Comparison of Original and Generic Atorvastatin for the Treatment of Moderate Dyslipidemic Patients

Comparison of Original and Generic Atorvastatin for the Treatment of Moderate Dyslipidemic Patients Comparison of Original and Generic Atorvastatin for the Treatment of Moderate Dyslipidemic Patients Cardiology Department, Bangkok Metropolitan Medical College and Vajira Hospital, Bangkok, Thailand Abstract

More information

The Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk

The Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk Update 2013 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine Denver Health

More information

Prevalence and pattern of Dyslipidaemia among patients with newly diagnosed type 2 diabetes mellitus in Southern Sri Lanka; a cross sectional study

Prevalence and pattern of Dyslipidaemia among patients with newly diagnosed type 2 diabetes mellitus in Southern Sri Lanka; a cross sectional study Prevalence and pattern of Dyslipidaemia among patients with newly diagnosed type 2 diabetes mellitus in Southern Sri Lanka; a cross sectional study 1 1 2 Herath HMM, Weerarathna TP, Weerasinghe NP 1 1

More information

Which CVS risk reduction strategy fits better to carotid US findings?

Which CVS risk reduction strategy fits better to carotid US findings? Which CVS risk reduction strategy fits better to carotid US findings? Dougalis A, Soulaidopoulos S, Cholongitas E, Chalevas P, Vettas Ch, Doumtsis P, Vaitsi K, Diavasti M, Mandala E, Garyfallos A 4th Department

More information

Microalbuminuria As Predictor Of Severity Of Coronary Artery Disease In Non-Diabetic Patients:

Microalbuminuria As Predictor Of Severity Of Coronary Artery Disease In Non-Diabetic Patients: ISPUB.COM The Internet Journal of Cardiology Volume 9 Number 1 Microalbuminuria As Predictor Of Severity Of Coronary Artery Disease In Non-Diabetic Patients: F Aziz, S Penupolu, S Doddi, A Alok, S Pervaiz,

More information

The promise of the thiazolidinediones in the management of type 2 diabetes-associated cardiovascular disease

The promise of the thiazolidinediones in the management of type 2 diabetes-associated cardiovascular disease The promise of the thiazolidinediones in the management of type 2 diabetes-associated cardiovascular disease Steve Smith, Group Director Scientific Affairs, Diabetes & Metabolism GlaxoSmithKline R & D

More information

A comparative study on the fasting and post prandial lipid levels as a cardiovascular risk factor in patients with type 2 diabetes mellitus

A comparative study on the fasting and post prandial lipid levels as a cardiovascular risk factor in patients with type 2 diabetes mellitus Original Research Article A comparative study on the fasting and post prandial lipid levels as a cardiovascular risk factor in patients with type 2 diabetes mellitus Deepa Kalikavil Puthenveedu 1, Sundaraj

More information

Relatively more atherogenic coronary heart disease risk factors in prediabetic women than in prediabetic men

Relatively more atherogenic coronary heart disease risk factors in prediabetic women than in prediabetic men Diabetologia (1997) 40: 711 717 Springer-Verlag 1997 Relatively more atherogenic coronary heart disease risk factors in prediabetic women than in prediabetic men S. M. Haffner 1, H. Miettinen 1,2, M. P.Stern

More information

The Diabetes Link to Heart Disease

The Diabetes Link to Heart Disease The Diabetes Link to Heart Disease Anthony Abe DeSantis, MD September 18, 2015 University of WA Division of Metabolism, Endocrinology and Nutrition Oswald Toosweet Case #1 68 yo M with T2DM Diagnosed DM

More information

Management of Cardiovascular Disease in Diabetes

Management of Cardiovascular Disease in Diabetes Management of Cardiovascular Disease in Diabetes Radha J. Sarma, MBBS, FACP. FACC. FAHA. FASE Professor of Internal Medicine Western University of Health Sciences. Director, Heart and Vascular Center Western

More information

Felix Vallotton Ball (1899) LDL-C management in Asian diabetes: moderate vs. high intensity statin --- a lesson from EMPATHY study

Felix Vallotton Ball (1899) LDL-C management in Asian diabetes: moderate vs. high intensity statin --- a lesson from EMPATHY study Felix Vallotton Ball (1899) LDL-C management in Asian diabetes: moderate vs. high intensity statin --- a lesson from EMPATHY study Conflict of interest disclosure None Committee of Scientific Affairs Committee

More information

The Metabolic Syndrome: Is It A Valid Concept? YES

The Metabolic Syndrome: Is It A Valid Concept? YES The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA

More information

DECLARATION OF CONFLICT OF INTEREST. None

DECLARATION OF CONFLICT OF INTEREST. None DECLARATION OF CONFLICT OF INTEREST None BURDEN OF CORONARY ARTERY DISEASE IN DIABETES IN INDIA Amal Kumar Banerjee MD, DM,FACC,FESC,FACP,FAPSC,FICC President Association of Physicians of India SAARC Cardiac

More information

The Burden of the Diabetic Heart

The Burden of the Diabetic Heart The Burden of the Diabetic Heart Dr. Ghaida Kaddaha (MBBS, MRCP-UK, FRCP-london) Diabetes Unit Rashid Hospital Dubai U.A.E Risk of CVD in Diabetes Morbidity and mortality from CVD is 2-4 fold higher than

More information

Early Detection of Asymptomatic Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus

Early Detection of Asymptomatic Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus ORIGINAL ARTICLE DOI: 10.3904/kjim.2009.24.3.183 Early Detection of Asymptomatic Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus Won Sang Yoo 1, Hee Jin Kim 1, Dohee Kim 1, Myung Yong

More information

Peripheral Arterial Occlusive Disease- The Challenge in patients with diabetes

Peripheral Arterial Occlusive Disease- The Challenge in patients with diabetes Peripheral Arterial Occlusive Disease- The Challenge in patients with diabetes Ashok Handa Reader in Surgery and Consultant Surgeon Nuffield Department of Surgery University of Oxford Introduction Vascular

More information

THE METABOLIC SYNDROME, A

THE METABOLIC SYNDROME, A ORIGINAL CONTRIBUTION The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged Men Hanna-Maaria Lakka, MD, PhD David E. Laaksonen, MD, MPH Timo A. Lakka, MD, PhD Leo K. Niskanen,

More information

JMSCR Vol 06 Issue 12 Page December 2018

JMSCR Vol 06 Issue 12 Page December 2018 www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i12.115 Evaluation of Carotid Intima

More information

CVD risk assessment using risk scores in primary and secondary prevention

CVD risk assessment using risk scores in primary and secondary prevention CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities

More information

Know Your Number Aggregate Report Single Analysis Compared to National Averages

Know Your Number Aggregate Report Single Analysis Compared to National Averages Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics

More information

SCIENTIFIC STUDY REPORT

SCIENTIFIC STUDY REPORT PAGE 1 18-NOV-2016 SCIENTIFIC STUDY REPORT Study Title: Real-Life Effectiveness and Care Patterns of Diabetes Management The RECAP-DM Study 1 EXECUTIVE SUMMARY Introduction: Despite the well-established

More information

Table S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416).

Table S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416). Table S1. Characteristics associated with frequency of nut (full entire sample; Nn=4,416). Daily nut Nn= 212 Weekly nut Nn= 487 Monthly nut Nn= 1,276 Infrequent or never nut Nn= 2,441 Sex; n (%) men 52

More information

Metabolic Syndrome in Female Patients with Ischaemic Heart Disease: A prospective study

Metabolic Syndrome in Female Patients with Ischaemic Heart Disease: A prospective study Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2017/470 Metabolic Syndrome in Female Patients with Ischaemic Heart Disease: A prospective study Ex. Maj. S K Gupta Graded

More information

Diabetes Mellitus. Eiman Ali Basheir. Mob: /1/2019

Diabetes Mellitus. Eiman Ali Basheir. Mob: /1/2019 Diabetes Mellitus Eiman Ali Basheir Mob: 091520385 27/1/2019 Learning Outcomes Discuss the WHO criteria for Diabetes Mellitus diagnosis Describe the steps taken to confirm diagnosis Interpret GTT. Discuss

More information

Impact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients

Impact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients 2012 International Conference on Life Science and Engineering IPCBEE vol.45 (2012) (2012) IACSIT Press, Singapore DOI: 10.7763/IPCBEE. 2012. V45. 14 Impact of Physical Activity on Metabolic Change in Type

More information

Diabetic Nephropathy. Objectives:

Diabetic Nephropathy. Objectives: There are, in truth, no specialties in medicine, since to know fully many of the most important diseases a man must be familiar with their manifestations in many organs. William Osler 1894. Objectives:

More information

Title for Paragraph Format Slide

Title for Paragraph Format Slide Title for Paragraph Format Slide Presentation Title: Month Date, Year Atherosclerosis A Spectrum of Disease: February 12, 2015 Richard Cameron Padgett, MD Executive Medical Director, OHVI Pt RB Age 38

More information

Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients

Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients ORIGINAL ARTICLES Epidemiologic and clinical comparison of renal artery stenosis in black patients and white patients Andrew C. Novick, MD, Safwat Zald, MD, David Goldfarb, MD, and Ernest E. Hodge, MD,

More information

Kidney and heart: dangerous liaisons. Luis M. RUILOPE (Madrid, Spain)

Kidney and heart: dangerous liaisons. Luis M. RUILOPE (Madrid, Spain) Kidney and heart: dangerous liaisons Luis M. RUILOPE (Madrid, Spain) Type 2 diabetes and renal disease: impact on cardiovascular outcomes The "heavyweights" of modifiable CVD risk factors Hypertension

More information

Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women

Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women European Heart Journal (2002) 23, 528 535 doi:10.1053/euhj.2001.2888, available online at http://www.idealibrary.com on Combined effects of systolic blood pressure and serum cholesterol on cardiovascular

More information

ARIC Manuscript Proposal # 979. PC Reviewed: 11/21/03 Status: Rejected Priority: SC Reviewed: Status: Priority:

ARIC Manuscript Proposal # 979. PC Reviewed: 11/21/03 Status: Rejected Priority: SC Reviewed: Status: Priority: ARIC Manuscript Proposal # 979 PC Reviewed: 11/21/03 Status: Rejected Priority: SC Reviewed: Status: Priority: 1.a. Full Title: Factors of the metabolic syndrome and incidence of coronary heart disease,

More information

Risk factors for microvascular and macrovascular complications in men and women with type 2 diabetes

Risk factors for microvascular and macrovascular complications in men and women with type 2 diabetes ORIGINAL PAPER Risk factors for microvascular and macrovascular complications in men and women with type 2 diabetes Per Erik Wändell Family Medicine Stockholm, Karolinska Institutet, Huddinge, Sweden.

More information

GUIDELINES FOR DYSLIPIDEMIA MANAGEMENT AND EDUCATION THROUGH NOVA SCOTIA DIABETES CENTRES

GUIDELINES FOR DYSLIPIDEMIA MANAGEMENT AND EDUCATION THROUGH NOVA SCOTIA DIABETES CENTRES GUIDELINES FOR DYSLIPIDEMIA MANAGEMENT AND EDUCATION THROUGH NOVA SCOTIA DIABETES CENTRES Prepared by DCPNS Action Committee Dr. Lynne Harrigan Brenda Cook Peggy Dunbar Bev Harpell with the assistance

More information

ABSTRACT ORIGINAL ARTICLE INTRODUCTION. e-issn: p-issn: doi: /apjhs G. Vikas Naik 1 *, K. P.

ABSTRACT ORIGINAL ARTICLE INTRODUCTION. e-issn: p-issn: doi: /apjhs G. Vikas Naik 1 *, K. P. ORIGINAL ARTICLE e-issn: 2349-0659 p-issn: 2350-0964 doi: 10.21276/apjhs.2018.5.1.21 Carotid intima-media thickness as a predictor of atherosclerosis in diabetic and non-diabetic subjects - A study from

More information

REAGENTS. RANDOX sdldl CHOLESTEROL (sdldl-c) SIZE MATTERS: THE TRUE WEIGHT OF RISK IN LIPID PROFILING

REAGENTS. RANDOX sdldl CHOLESTEROL (sdldl-c) SIZE MATTERS: THE TRUE WEIGHT OF RISK IN LIPID PROFILING REAGENTS RANDOX sdldl CHOLESTEROL (sdldl-c) SIZE MATTERS: THE TRUE WEIGHT OF RISK IN LIPID PROFILING Randox sdldl Cholesterol (sdldl-c) Size Matters: The True Wight of Risk in Lipid Profiling 1. BACKGROUND

More information

HIHIM Clinical Cocepts for Managers 7/31/2009. Fernando Vega, MD 1

HIHIM Clinical Cocepts for Managers 7/31/2009. Fernando Vega, MD 1 Fernando Vega, MD HIHIM 409 July 31, 2008 Hyperglycemia characterized by relative or absolute lack of insulin secretion Varying degrees of insulin resistance Often associated with symptoms: polyruia, polydipsia,

More information

A study on clinical profile of acute coronary syndrome in type 2 diabetes mellitus patients with relevance to HbA1c

A study on clinical profile of acute coronary syndrome in type 2 diabetes mellitus patients with relevance to HbA1c Original Research Article A study on clinical profile of acute coronary syndrome in type 2 diabetes mellitus patients with relevance to HbA1c K. Babu Raj 1, G. Sivachandran 2* 1 Reader, 2 Final Year Post

More information

Impact of Chronicity on Lipid Profile of Type 2 Diabetics

Impact of Chronicity on Lipid Profile of Type 2 Diabetics Impact of Chronicity on Lipid Profile of Type 2 Diabetics Singh 1, Gurdeep & Kumar 2, Ashok 1 Ph.D. Research Scholar, Department of Sports Science, Punjabi University Patiala, India, Email: drgurdeep_sahni@yahoo.co.in

More information

Available from Deakin Research Online: Copyright : 2007, International Diabetes Institute

Available from Deakin Research Online:   Copyright : 2007, International Diabetes Institute Deakin Research Online Deakin University s institutional research repository DDeakin Research Online Research Online This is the authors final peer reviewed version of the item published as: Cameron, A.

More information

Soo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital

Soo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital Soo LIM, MD, PHD Internal Medicine Seoul National University Bundang Hospital 1. Importance of Lowering LDL-Cholesterol in Diabetes Patients & Lipid Guidelines Prevalence of dyslipidemia in Korea Prevalence

More information

Isolated Post-challenge Hyperglycemia: Concept and Clinical Significance

Isolated Post-challenge Hyperglycemia: Concept and Clinical Significance CLINICAL PRACTICE Isolated Post-challenge Hyperglycemia: Concept and Clinical Significance John MF. Adam*, Daniel Josten** ABSTRACT The American Diabetes Association has strongly recommended that fasting

More information

Metabolic syndrome and insulin resistance in an urban and rural adult population in Sri Lanka

Metabolic syndrome and insulin resistance in an urban and rural adult population in Sri Lanka Original Metabolic paper syndrome and insulin resistance in an urban and rural adult population in Sri Lanka Metabolic syndrome and insulin resistance in an urban and rural adult population in Sri Lanka

More information

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY MCC-006 POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) 00269 Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY Time : 2 hours Maximum Marks : 60 Note : There will be multiple

More information

Frequency of proteinuria in type 2 diabetes mellitus seen at a diabetes centre in southern India

Frequency of proteinuria in type 2 diabetes mellitus seen at a diabetes centre in southern India Postgrad Med J 2000;76:569 573 569 AUDIT Madras Diabetes Research Foundation and M V Diabetes Specialities Centre (P) Ltd, Gopalapuram, Chennai, India V Mohan G Premalatha R Deepa P Miranda M Rema City

More information

Atherosclerotic Disease Risk Score

Atherosclerotic Disease Risk Score Atherosclerotic Disease Risk Score Kavita Sharma, MD, FACC Diplomate, American Board of Clinical Lipidology Director of Prevention, Cardiac Rehabilitation and the Lipid Management Clinics September 16,

More information

Hyperlipidemia and Cardiovascular Risk Factors in Patients With Type 2 Diabetes

Hyperlipidemia and Cardiovascular Risk Factors in Patients With Type 2 Diabetes ...PRESENTATIONS... Hyperlipidemia and Cardiovascular Risk Factors in Patients With Type 2 Diabetes Based on a presentation by Ronald B. Goldberg, MD Presentation Summary Atherosclerosis accounts for approximately

More information

Metabolic Syndrome: Why Should We Look For It?

Metabolic Syndrome: Why Should We Look For It? 021-CardioCase 29/05/06 15:04 Page 21 Metabolic Syndrome: Why Should We Look For It? Dafna Rippel, MD, MHA and Andrew Ignaszewski, MD, FRCPC CardioCase presentation Andy s fatigue Andy, 47, comes to you

More information